University of Washington
The investigators would like to improve our understanding of how early intervention with the use of bladder chemodenervation can preserve bladder function in those with a new SCI. Although detrimental cystometric and tissue changes are known to occur, often within 3 months after SCI, the investigators seek to document the time course of these changes and the range of severity of those changes in both those participants that receive prophylactic treatment and those who do not.
Inclusion Criteria: * Male or female 18-65 years of age at time of SCI. * English speaking * Recent SCI (within 20 weeks of injury). * Documentation of a spinal cord injury at T6 or higher, American Spinal Injury Association Impairment Scale (AIS) level A or B as designated on initial (72 hour) AIS exam. * Ability for subject to comply with the requirements of the study. * Written informed consent obtained from subject. Exclusion Criteria: * Inability to return to research site (Harborview Medical Center) for follow-up studies after initial hospitalization. * Acute (as part of concurrent ho…
BoNT-A (Botox) 200 U will be injected into the detrusor (bladder wall muscle).
20mL placebo (saline only), will be injected into the detrusor (bladder wall muscle).
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.